“AN OBSERVATIONAL STUDY OF HIGH FLOW NASAL OXYGEN THERAPY IN COVID 19 PATIENTS ADMITTED IN INTENSIVE CARE UNITâ€
Not yet recruiting
- Conditions
- Coronavirus as the cause of diseases classified elsewhere,
- Registration Number
- CTRI/2020/12/029563
- Lead Sponsor
- Not applicable
- Brief Summary
This is an observational study of the utility of HFNO therapy in managing respiratory failure in moderate to severe COVID 19 patients who are admitted in intensive care unit and also to identify the early predictors of HFNO failure.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
1.Patients between age 18-60years 2.Both males and females 3.Patients with type 1 respiratory failure 4.Patients with SpO2 less than or equal to 92% on room air 5.Patients with or without co morbidities.
Exclusion Criteria
- 1.Patient’s refusal for HFNO 2.Patients below 18years and above 60years 3.
- Patients with tracheostomy 4.
- Patients with Claustrophobia 5.Patients with urgent need for endotracheal intubation 6.Patients with GCS less than 8 or raised intracranial tension 7.Patients with upper airway obstruction 8.
- Pregnant patients.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Whether high flow nasal oxygen therapy can treat hypoxia in COVID 19 patients During ICU stay
- Secondary Outcome Measures
Name Time Method 1.To analise failure rate of high flow nasal oxygen therapy in COVID 19 patients and escalation to invasive and non-invasive ventilation. during ICU stay
Trial Locations
- Locations (1)
St George Hospital
🇮🇳Mumbai, MAHARASHTRA, India
St George Hospital🇮🇳Mumbai, MAHARASHTRA, IndiaDrAshwin sonkamblePrincipal investigator9850961196seeashwin@rediffmail.com